These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 30267088
1. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease. Yi S, Chang R, Hu J, Qiu Y, Wang Q, Cao Q, Yuan G, Su G, Zhou C, Wang Y, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2018 Sep 04; 59(11):4662-4669. PubMed ID: 30267088 [Abstract] [Full Text] [Related]
2. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease. He Y, Wang C, Su G, Deng B, Ye Z, Huang Y, Yuan G, Aize K, Li H, Yang P. Br J Ophthalmol; 2018 Aug 04; 102(8):1167-1172. PubMed ID: 29699987 [Abstract] [Full Text] [Related]
3. Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet's Disease (BD). Deng B, Ye Z, Li L, Zhang D, Zhu Y, He Y, Wang C, Wu L, Kijlstra A, Yang P. Curr Mol Med; 2016 Aug 04; 16(4):424-35. PubMed ID: 26980698 [Abstract] [Full Text] [Related]
4. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome. Zhou Q, Xiao X, Wang C, Zhang X, Li F, Zhou Y, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2012 Aug 17; 53(9):5665-74. PubMed ID: 22815348 [Abstract] [Full Text] [Related]
5. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2012 Jul 10; 53(8):4668-75. PubMed ID: 22669715 [Abstract] [Full Text] [Related]
6. Berberine suppresses Th17 and dendritic cell responses. Yang Y, Qi J, Wang Q, Du L, Zhou Y, Yu H, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2013 Apr 05; 54(4):2516-22. PubMed ID: 23482469 [Abstract] [Full Text] [Related]
7. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease. Peng Z, Jiang S, Wu M, Zhou X, Wang Q. Mol Vis; 2017 Apr 05; 23():538-547. PubMed ID: 28761327 [Abstract] [Full Text] [Related]
8. Increased Expression of Indoleamine 2,3-Dioxygenase (IDO) in Vogt-Koyanagi-Harada (VKH) Disease May Lead to a Shift of T Cell Responses Toward a Treg Population. Zhang L, Huang Y, Cui X, Tan X, Zhu Y, Zhou W, Wang C, Yuan G, Cao Q, Su G, Kijlstra A, Yang P. Inflammation; 2020 Oct 05; 43(5):1780-1788. PubMed ID: 32435912 [Abstract] [Full Text] [Related]
9. Promoter Hypermethylation of GATA3, IL-4, and TGF-β Confers Susceptibility to Vogt-Koyanagi-Harada Disease in Han Chinese. Zhu Y, Yu H, Qiu Y, Ye Z, Su W, Deng J, Cao Q, Yuan G, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2017 Mar 01; 58(3):1529-1536. PubMed ID: 28278322 [Abstract] [Full Text] [Related]
10. Increased IL-7 expression in Vogt-Koyanagi-Harada disease. Yang Y, Xiao X, Li F, Du L, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1012-7. PubMed ID: 22247488 [Abstract] [Full Text] [Related]
11. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease. Wu L, Wen H, Zhou Y, Yu H, Liu Y, Bai L, Kijlstra A, Yang P. Curr Mol Med; 2014 Feb 27; 14(6):712-22. PubMed ID: 25056541 [Abstract] [Full Text] [Related]
12. Hypermethylation of Interferon Regulatory Factor 8 (IRF8) Confers Risk to Vogt-Koyanagi-Harada Disease. Qiu Y, Yu H, Zhu Y, Ye Z, Deng J, Su W, Cao Q, Yuan G, Kijlstra A, Yang P. Sci Rep; 2017 Apr 21; 7(1):1007. PubMed ID: 28432342 [Abstract] [Full Text] [Related]
13. Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease. Yang J, Hu J, Feng L, Yi S, Ye Z, Lin M, Liu X, Pu Y, Kijlstra A, Yang P, Li H. Ocul Immunol Inflamm; 2020 Apr 21; 28(2):200-208. PubMed ID: 30794473 [Abstract] [Full Text] [Related]
14. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease. Chang R, Yi S, Tan X, Huang Y, Wang Q, Su G, Zhou C, Cao Q, Yuan G, Kijlstra A, Yang P. Br J Ophthalmol; 2018 Feb 21; 102(2):282-290. PubMed ID: 28972028 [Abstract] [Full Text] [Related]
15. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease. Sun M, Yang P, Du L, Yang Y, Ye J. PLoS One; 2014 Feb 21; 9(4):e93214. PubMed ID: 24690905 [Abstract] [Full Text] [Related]
16. The Rs12569232 SNP Association with Vogt-Koyanagi-Harada Disease and Behcet's Disease is Probably Mediated by Regulation of Linc00467 Expression. Wang Q, Yi S, Du Z, Huang X, Xu J, Cao Q, Su G, Kijlstra A, Yang P. Ocul Immunol Inflamm; 2021 Nov 17; 29(7-8):1464-1470. PubMed ID: 32400232 [Abstract] [Full Text] [Related]
17. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M. Invest Ophthalmol Vis Sci; 2006 Jun 17; 47(6):2547-54. PubMed ID: 16723469 [Abstract] [Full Text] [Related]
18. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease. Li F, Yang P, Liu X, Wang C, Hou S, Kijlstra A. Arch Ophthalmol; 2010 Nov 17; 128(11):1449-54. PubMed ID: 21060047 [Abstract] [Full Text] [Related]
19. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease. Wang C, Wang L, Hu J, Li H, Kijlstra A, Yang P. Curr Eye Res; 2018 Nov 17; 43(11):1369-1373. PubMed ID: 29877734 [Abstract] [Full Text] [Related]
20. Decreased interleukin(IL)-35 Expression is Associated with Active Intraocular Inflammation in Vogt-Koyanagi-Harada (VKH) Disease. Hu J, Qin Y, Yi S, Wang C, Yang J, Yang L, Wang L, Kijlstra A, Yang P, Li H. Ocul Immunol Inflamm; 2019 Nov 17; 27(4):595-601. PubMed ID: 29498905 [Abstract] [Full Text] [Related] Page: [Next] [New Search]